Seres Therapeutics Announces Results Involving SER-109 Therapy For Recurrent C. Difficile Infection
Medically reviewed by Onikepe Adegbola, MD, PhD Today, Seres Therapeutics, Inc. released confirmed findings from ECOSPOR IV, an open-label trial ...
Tag: seres therapeutics
Dope Entrepreneurs is the hub for all dope gut health related content. We are a groundbreaking news publication dedicated to gut health. We cover gut health research, entrepreneurship, startups and the latest trends in gut health. We serve a growing segment of patients, entrepreneurs and investors who want to learn more about gut health, the disruption and market potential in this field, and how they can benefit from the latest advances in gut health. Dope entrepreneurs is led by Onikepe Adegbola, MD PhD DipIBLM, physician, scientist, and gut health entrepreneur.